dc.contributor.author | Martinez, José William | spa |
dc.contributor.author | Martínez Muñoz, Manuel A. | spa |
dc.contributor.author | López Osorio, Juliet J | spa |
dc.contributor.author | Marín Medina, Daniel S | spa |
dc.contributor.author | Orozco Hernández, Juan P | spa |
dc.contributor.author | Sosa Urrea, Juan D | spa |
dc.contributor.author | Sánchez Duque, Jorge Andrés | spa |
dc.date.accessioned | 2020-10-27T14:19:38Z | |
dc.date.available | 2020-10-27T14:19:38Z | |
dc.date.issued | 2017-04-01 | |
dc.identifier.issn | 2382-4603 | |
dc.identifier.issn | 0123-7047 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12749/10012 | |
dc.description.abstract | Pseudomonas aeruginosa es una bacteria oportunista Gram negativa particularmente eficiente en la adquisición de mecanismos de resistencia y de alta prevalencia en infecciones nosocomiales en pacientes oncológicos. Objetivo: identificar los factores de riesgo para mortalidad en pacientes oncológicos con aislamiento de P. aeruginosa. Metodología: estudio descriptivo, la población de estudio fueron los casos reportados con aislamiento de P. aeruginosa en el servicio de hospitalización de Oncólogos de Occidente en Pereira, Armenia y Manizales durante el año 2015. Se realizaron análisis univariados y multivariados; la supervivencia se estableció según el método de Kaplan-Meier. Se estableció un valor de p <0.05. Se usó el software STATA. Se tuvo aval de bioética de la Universidad Tecnológica de Pereira. Resultados: se estudió 41 casos confirmados de cultivos positivos de P. aeruginosa. El sexo masculino (46.3%), anemia (46.3%), neutropenia febril (41%), trombocitopenia (29.3%) y haber sido hospitalizado en la unidad de cuidados intensivos (29.3%) fueron asociados estadísticamente con mayor mortalidad (p=0.019); con estos resultados se diseñó una escala de riesgo (alfa de Cronbach =0.72). Los pacientes con cuatro de estas exposiciones mostraron mayor riesgo de mortalidad al egreso hospitalario con una sensibilidad del 68% y especificidad del 90%. La P. aeruginosa presentó resistencia a cefepime (36.6%) y a aztreonam (34.1%), mientras que la letalidad global fue del 26.8%. Conclusión: El sexo masculino, la coexistencia de anemia, trombocitopenia, y neutropenia febril, así como la estancia en la unidad de cuidados intensivos aumentan la mortalidad en los pacientes oncológicos infectados con P. aeruginosa. | spa |
dc.format.mimetype | application/pdf | spa |
dc.format.mimetype | Application/vnd.openxmlformats-officedocument.wordprocessingml.document | spa |
dc.language.iso | spa | spa |
dc.publisher | Universidad Autónoma de Bucaramanga UNAB | |
dc.relation | https://revistas.unab.edu.co/index.php/medunab/article/view/2666/2340 | |
dc.relation | Https://revistas.unab.edu.co/index.php/medunab/article/view/2666/2745 | |
dc.relation.uri | https://revistas.unab.edu.co/index.php/medunab/article/view/2666 | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/co/ | |
dc.source | MedUNAB; Vol. 20 Núm. 1 (2017): Abril - Julio de 2017: Mortalidad Neonatal, Carga de Cuidado, Infección Hospitalaria; 39-47 | |
dc.title | Factores de riesgo para mortalidad en la infección por Pseudomonas aeruginosa en pacientes oncológicos hospitalizados en tres ciudades de Colombia | spa |
dc.title.translated | Risk factors for mortality caused by pseudomonas aeruginosa infection in hospitalized patients with oncologic diagnosis in three cities of Colombia | eng |
dc.publisher.faculty | Facultad Ciencias de la Salud | spa |
dc.publisher.program | Pregrado Medicina | spa |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.local | Artículo | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | |
dc.subject.keywords | Pseudomonas aeruginosa | eng |
dc.subject.keywords | Neoplasms | eng |
dc.subject.keywords | Cross infection | eng |
dc.subject.keywords | Drug resistance | eng |
dc.subject.keywords | Microbial | eng |
dc.identifier.instname | instname:Universidad Autónoma de Bucaramanga UNAB | spa |
dc.type.hasversion | Info:eu-repo/semantics/publishedVersion | |
dc.type.hasversion | info:eu-repo/semantics/acceptedVersion | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.relation.references | BodeyGP.Pseudomonasaeruginosainfectionsin cancer patients: have they gone away? Curr Opin Infect Dis. 2001;14(4):403-7 | spa |
dc.relation.references | Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. NHSNannual update: antimicrobial-resistantpathogensassociatedwithhealthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011 | spa |
dc.relation.references | Bou R, Aguilar A, Perpinan J, Ramos P, Peris M, Lorente L,etal.NosocomialoutbreakofPseudomonas aeruginosa infections related to a flexible bronchoscope. J Hosp Infect. 2006;64(2):129-35 | spa |
dc.relation.references | Molina F, Díaz C, Barrera L, De La Rosa G, Dennis R, Dueñas C, et al. Perfil microbiológico de la Infecciones enUnidadesdeCuidadosIntensivosdeColombia (EPISEPSISColombia).MedicinaIntensiva. 2011;35(2):75-83 | spa |
dc.relation.references | JroundiI,KhoudriI,AzzouziA,ZeggwaghAA, Benbrahim NF, Hassouni F, et al. Prevalence of hospital-acquired infection in a Moroccan university hospital. American journal of infection control. 2007;35(6):412-6 | spa |
dc.relation.references | Dobbs TE, Guh AY, Oakes P, Vince MJ, Forbi JC, Jensen B, et al. Outbreak of Pseudomonas aeruginosa and Klebsiella pneumoniae bloodstream infections at an outpatient chemotherapy center. Am J Infect Control. 2014;42(7):731-4 | spa |
dc.relation.references | Falagas ME, Kopterides P. Risk factors for the isolation ofmulti-drug-resistantAcinetobacterbaumanniiand Pseudomonas aeruginosa: a systematic review of the literature. Journal of Hospital Infection. 2006;64(1):7-15 | spa |
dc.relation.references | GiamarellouH.Multidrug-resistantGram-negative bacteria: how to treat and for how long. International Journal of Antimicrobial Agents. 2010;36, Supplement 2(0):S50-S4 | spa |
dc.relation.references | Briceno DF, Correa A, Valencia C, Torres JA, Pacheco R, Montealegre MC, et al. Antimicrobial resistance of Gram negative bacilli isolated from tertiary-care hospitals in Colombia. Biomedica : revista del Instituto Nacional de Salud. 2010;30(3):371-81 | spa |
dc.relation.references | Martínez Buitrago E, Hernández C, Pallares C, Pacheco R, Hurtado K, Recalde M. Frecuencia de aislamientos microbiológicos y perfil de resistencia bacteriana en 13 clínicas y hospitales de alta complejidad en Santiago de Cali-Colombia. Infectio. 2014;18(1):3-11 | spa |
dc.subject.lemb | Ciencias medicas | spa |
dc.subject.lemb | Ciencias de la salud | spa |
dc.subject.lemb | Medicina | spa |
dc.identifier.repourl | repourl:https://repository.unab.edu.co | |
dc.description.abstractenglish | Pseudomonas aeruginosa is a Gram-negative and rod-shape opportunistic bacterium that is particularly efficient in the acquisition of resistance mechanisms and its high prevalence in nosocomial infections in cancer patients. Objective: To identify risk factors for mortality in cancer patients with P. aeruginosa infection. Methodology: A descriptive study was carried out in patients with P. aeruginosa infection during the hospitalization service of “Oncólogos de Occidente” in Pereira, Armenia and Manizales during 2015. Univariate and multivariate analyzes were performed. The survival analysis was established according to the Kaplan-Meier method. A value of p<0.05 was established for it. The analyses were examined with the STATA software. This study was endorsed by the bioethics committee of the “Universidad Tecnológica de Pereira”. Results: Fourty-one patients with positive culture for P. aeruginosa were studied. Males (46.3%), anemia (46.3%), febrile neutropenia (41%), thrombocytopenia (29.3%) and previous hospitalization in an intensive care unit (29.3%) were associated with higher mortality risk (p = 0.019); a risk scale was designed with these factors (Cronbach´s alpha = 0.72). Patients who presented four of these exposures were at higher risk of mortality with a sensitivity of 68% and specificity of 90% at the moment of discharge. P. aeruginosa showed 36.6% of resistance to cefepime, 34.1% to aztreonam, the mortality rate was 26.8%. Conclusion: Male sex, anemia, thrombocytopenia, febrile neutropenia and previous hospitalization in an intensive care unit increase the mortality rate in patients with cancer who were infected by P. aeruginosa. | eng |
dc.subject.proposal | Pseudomonas aeruginosa | spa |
dc.subject.proposal | Neoplasias | spa |
dc.subject.proposal | Infección hospitalaria | spa |
dc.subject.proposal | Farmacorresistencia microbiana | spa |
dc.subject.proposal | Colombia | spa |
dc.identifier.doi | 10.29375/01237047.2666 | |
dc.type.redcol | http://purl.org/redcol/resource_type/ART | |